A novel coating technology based upon polyatomic ions from plasma

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:4 publications

Grant number: EP/S004505/1

Grant search

Key facts

  • Disease

  • Funder

    UK Research and Innovation (UKRI)
  • Principle Investigator

  • Research Location

    United Kingdom, Europe
  • Lead Research Institution

    Lancaster University
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Environmental stability of pathogen

  • Special Interest Tags


  • Study Subject


  • Clinical Trial Details


  • Broad Policy Alignment


  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable


This project tackles fomite transmission to provide enhanced protection (key workers) and prevent (public) transmission during the current CoVID-19 (SARS-CoV-2) outbreak, and to safeguard against future pandemics. As we understand more about how the virus is spread (by droplets) there is a need for practical interventions to prevent spread from surfaces. Six months allows PI (Short) to work with Virologist (Munir). First tangible results will be < 6 months. Coatings are assessed within Cat 3 facilities using plaque and molecular assays to determine deactivation of SARS-CoV-2 by contact. Candidate coatings will be assessed on 8 real-world materials and leveraging upon a significant knowledge of translation and scale-up, within < 12 months, real-world objects will be coated and deployed.

Publicationslinked via Europe PMC

Last Updated:38 minutes ago

View all publications at Europe PMC

Melanins as Sustainable Resources for Advanced Biotechnological Applications.

Plasma polymerization of (2,2,6,6-tetramethylpiperidin-1-yl)oxyl in a collisional, capacitively coupled radio frequency discharge.

Phenolic-Enriched Collagen Fibrillar Coatings on Titanium Alloy to Promote Osteogenic Differentiation and Reduce Inflammation.

Dairy-Inspired Coatings for Bone Implants from Whey Protein Isolate-Derived Self-Assembled Fibrils.